Moderna (MRNA) earnings, Nov 6, 2026: quarterly results
In brief
Moderna reported on Nov 6, 2026. Earnings per share changed +175% year over year, 134.7% above the estimate; revenue +29%. The stock is now 7.5% below its 52-week high, +924.9% over 12 months. Next report: Feb 25, 2027.
EPS vs estimate+134.7%
EPS, YoY+175%
Revenue, YoY+29%
Gap · day— · —
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 31, 2026 | +0.2% | +0.6% |
Next-quarter estimates, ratings and the MRNA chart are in the terminal.
Open the terminalFAQ
When is Moderna's next earnings report?
Feb 25, 2027. The date comes from daily data and is corrected if the company moves it.
Did Moderna's earnings grow?
Earnings per share rose 175% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.